Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet α2 receptors: G(i) protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity

George N M Gurguis, Kimberly A. Yonkers, Stephanie P. Phan, Jaishri E. Blakeley, Anita Williams, A. John Rush

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Background: Abnormal α2-adrenergic receptor (AR) function is implicated in anxiety and depressive disorders. Premenstrual dysphoric disorder (PMDD) is characterized by anxiety and depressive symptoms, which may be associated with changes in α2AR function. Previous studies on α2AR function during phases of the menstrual cycle in controls and PMDD patients are inconsistent. Methods: α2AR function was examined in 16 PMDD patients and 15 controls during the follicular phase, and in 10 PMDD patients during late luteal phase. Antagonist-measured maximum binding capacity, agonist- measured receptor density in high- and low-conformational states, and agonist affinity to both states were measured. Coupling efficiency to G(i) protein was estimated. Results: There were no significant differences in coupling efficiency. PMDD patients had significantly low antagonist affinity; there were no differences in other binding parameters. There were no changes in α2AR binding parameters between phases of menstrual cycle in PMDD women. α2AR density and symptom severity were inversely related during the follicular phase in controls and patients. During luteal phase, α2AR density correlated positively with symptom severity in patients. High follicular α2AR density predicted more severe luteal symptoms in PMDD patients. Conclusions: These findings are discussed in view of the molecular biology of α2AR, and their role in PMDD, anxiety, and depressive disorders.

Original languageEnglish (US)
Pages (from-to)600-609
Number of pages10
JournalBiological Psychiatry
Volume44
Issue number7
DOIs
StatePublished - Oct 1 1998

Fingerprint

Luteal Phase
Menstrual Cycle
Adrenergic Receptors
Blood Platelets
Proteins
Follicular Phase
Depressive Disorder
Anxiety Disorders
Premenstrual Dysphoric Disorder
Corpus Luteum
Molecular Biology
Anxiety
Depression

Keywords

  • Alpha-adrenergic receptors
  • Anxiety
  • Coupling
  • Depression
  • G protein
  • Premenstrual syndrome

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Adrenergic receptors in premenstrual dysphoric disorder : I. Platelet α2 receptors: G(i) protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. / Gurguis, George N M; Yonkers, Kimberly A.; Phan, Stephanie P.; Blakeley, Jaishri E.; Williams, Anita; Rush, A. John.

In: Biological Psychiatry, Vol. 44, No. 7, 01.10.1998, p. 600-609.

Research output: Contribution to journalArticle

Gurguis, George N M ; Yonkers, Kimberly A. ; Phan, Stephanie P. ; Blakeley, Jaishri E. ; Williams, Anita ; Rush, A. John. / Adrenergic receptors in premenstrual dysphoric disorder : I. Platelet α2 receptors: G(i) protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. In: Biological Psychiatry. 1998 ; Vol. 44, No. 7. pp. 600-609.
@article{7074939a2b524e01b97cb5e364cc600b,
title = "Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet α2 receptors: G(i) protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity",
abstract = "Background: Abnormal α2-adrenergic receptor (AR) function is implicated in anxiety and depressive disorders. Premenstrual dysphoric disorder (PMDD) is characterized by anxiety and depressive symptoms, which may be associated with changes in α2AR function. Previous studies on α2AR function during phases of the menstrual cycle in controls and PMDD patients are inconsistent. Methods: α2AR function was examined in 16 PMDD patients and 15 controls during the follicular phase, and in 10 PMDD patients during late luteal phase. Antagonist-measured maximum binding capacity, agonist- measured receptor density in high- and low-conformational states, and agonist affinity to both states were measured. Coupling efficiency to G(i) protein was estimated. Results: There were no significant differences in coupling efficiency. PMDD patients had significantly low antagonist affinity; there were no differences in other binding parameters. There were no changes in α2AR binding parameters between phases of menstrual cycle in PMDD women. α2AR density and symptom severity were inversely related during the follicular phase in controls and patients. During luteal phase, α2AR density correlated positively with symptom severity in patients. High follicular α2AR density predicted more severe luteal symptoms in PMDD patients. Conclusions: These findings are discussed in view of the molecular biology of α2AR, and their role in PMDD, anxiety, and depressive disorders.",
keywords = "Alpha-adrenergic receptors, Anxiety, Coupling, Depression, G protein, Premenstrual syndrome",
author = "Gurguis, {George N M} and Yonkers, {Kimberly A.} and Phan, {Stephanie P.} and Blakeley, {Jaishri E.} and Anita Williams and Rush, {A. John}",
year = "1998",
month = "10",
day = "1",
doi = "10.1016/S0006-3223(98)00097-3",
language = "English (US)",
volume = "44",
pages = "600--609",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "7",

}

TY - JOUR

T1 - Adrenergic receptors in premenstrual dysphoric disorder

T2 - I. Platelet α2 receptors: G(i) protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity

AU - Gurguis, George N M

AU - Yonkers, Kimberly A.

AU - Phan, Stephanie P.

AU - Blakeley, Jaishri E.

AU - Williams, Anita

AU - Rush, A. John

PY - 1998/10/1

Y1 - 1998/10/1

N2 - Background: Abnormal α2-adrenergic receptor (AR) function is implicated in anxiety and depressive disorders. Premenstrual dysphoric disorder (PMDD) is characterized by anxiety and depressive symptoms, which may be associated with changes in α2AR function. Previous studies on α2AR function during phases of the menstrual cycle in controls and PMDD patients are inconsistent. Methods: α2AR function was examined in 16 PMDD patients and 15 controls during the follicular phase, and in 10 PMDD patients during late luteal phase. Antagonist-measured maximum binding capacity, agonist- measured receptor density in high- and low-conformational states, and agonist affinity to both states were measured. Coupling efficiency to G(i) protein was estimated. Results: There were no significant differences in coupling efficiency. PMDD patients had significantly low antagonist affinity; there were no differences in other binding parameters. There were no changes in α2AR binding parameters between phases of menstrual cycle in PMDD women. α2AR density and symptom severity were inversely related during the follicular phase in controls and patients. During luteal phase, α2AR density correlated positively with symptom severity in patients. High follicular α2AR density predicted more severe luteal symptoms in PMDD patients. Conclusions: These findings are discussed in view of the molecular biology of α2AR, and their role in PMDD, anxiety, and depressive disorders.

AB - Background: Abnormal α2-adrenergic receptor (AR) function is implicated in anxiety and depressive disorders. Premenstrual dysphoric disorder (PMDD) is characterized by anxiety and depressive symptoms, which may be associated with changes in α2AR function. Previous studies on α2AR function during phases of the menstrual cycle in controls and PMDD patients are inconsistent. Methods: α2AR function was examined in 16 PMDD patients and 15 controls during the follicular phase, and in 10 PMDD patients during late luteal phase. Antagonist-measured maximum binding capacity, agonist- measured receptor density in high- and low-conformational states, and agonist affinity to both states were measured. Coupling efficiency to G(i) protein was estimated. Results: There were no significant differences in coupling efficiency. PMDD patients had significantly low antagonist affinity; there were no differences in other binding parameters. There were no changes in α2AR binding parameters between phases of menstrual cycle in PMDD women. α2AR density and symptom severity were inversely related during the follicular phase in controls and patients. During luteal phase, α2AR density correlated positively with symptom severity in patients. High follicular α2AR density predicted more severe luteal symptoms in PMDD patients. Conclusions: These findings are discussed in view of the molecular biology of α2AR, and their role in PMDD, anxiety, and depressive disorders.

KW - Alpha-adrenergic receptors

KW - Anxiety

KW - Coupling

KW - Depression

KW - G protein

KW - Premenstrual syndrome

UR - http://www.scopus.com/inward/record.url?scp=18744420345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744420345&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(98)00097-3

DO - 10.1016/S0006-3223(98)00097-3

M3 - Article

C2 - 9787884

AN - SCOPUS:18744420345

VL - 44

SP - 600

EP - 609

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 7

ER -